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Summary
Introduction: The mandible is an infrequent localisation of primary osseous non-Hodgkin’s lymphomas. Few cases of 
mandibular non-Hodgkin’s lymphomas (NHL) have been reported.
Case report: A rare condition of primary malignant non-Hodgkin’s lymphoma of the mandible in 53-year-old man, was 
reported at the Department of Maxillofacial and Plastic Surgery in Charles Nicolle Hospital (Tunis, Tunisia).
Histologic and Immunohistochemical (IHC) examination Conﬁ  rmed a B-Cell lymphoma.
Discussion: The purpose of this report is to describe this rare case of NHL of the mandible, explore the diagnosis and 
workup, and discuss treatment strategies.
In this localisation, neither the clinical features nor the radiologic appearances are often pathognomonic.
Conclusion: Particular care must be taken to consider lymphoma in the differential diagnosis because this uncommon lesion 
can pose signiﬁ  cant diagnostic problems and is frequently misdiagnosed.
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Introduction
Non-Hodgkin’s lymphoma (NHL) arises primarily within the lymph nodes, but approximately 24% affect 
extranodal locations.
1,2 The most frequent extranodal sites include the gastrointestinal tract, skin, bones, 
and Waldeyer’s ring.
1,3 NHL of bone is rare, representing only 5% of all extranodal lymphomas.
3
The mandible accounts for only 0.6% of isolated malignant non-Hodgkin’s lymphomas.
2 This 
uncommon localisation can pose signiﬁ  cant diagnostic problems and is frequently misdiagnosed.
4,5
We present a rare case of primary lymphoma of the mandible. To our knowledge, there are only a 
few reports on this condition.
Case Report
A 53-year-old male with a past history of vague pain along his left mandible was referred to the department 
of Maxillofacial and Plastic Surgery at Charles Nicolle Hospital.
Six months previously he had undergone the extraction of the sixth lower left tooth.
He then began noting pain in the vicinity of the previous extraction site and left lower lip numbness 
developed.
The panoramic radiograph showed a large radiolucent lesion with irregular margins in the left part 
of the mandible (Fig. 1).
This was thought to be ‘‘osteomyelitis’’ or an‘‘abscess’’ and he was treated with a course of 
antibiotics.
Then, the patient presented a gradually swelling on the left mandibular in molar area, with paresthesia 
of the ipsilateral lower lip.446
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Extraoral examination showed a left mandibular 
body swelling, that measured 3*3 cm, expanding 
both laterally and inferiorly with no lymphade-
nopathy.
The intraoral examination showed the presence 
of an expansive lesion of the mandible with normal 
appearing overlying mucosa. It was tender and 
painful.
At the time of presentation, the patient did not 
report any systemic symptoms and had no fever, 
weight loss, or dysphagia.
Computed tomography (CT) of the head and 
neck performed with i.v. ioded medium showed a 
wide osteolytic area in the left part of the mandible 
(Figs. 2, 3); no presence of latero-cervical lymph 
node lesions was noted.
Incisional biopsy was done and showed dense 
infiltration of cells with small round hyper 
chromatic nucleolus and scant cytoplasm resembled 
lymphocyte (Fig. 4).
Immunohistochemical (IHC) examination 
revealed CD20 and PanB positive cells (Fig. 5). 
This ﬁ  nding conﬁ  rmed a B-Cell origin for this 
monomorphic proliferation.
The total body CT scan with i.v.ioded medium 
and bone marrow aspiration biopsy conﬁ  rmed the 
mandible as the only localisation of the pathology. 
He therefore was categorized as stage IAE, primary 
mandibular NHL.
The patient refuses all treatment by radio and 
chemotherapy. He has remained free of disease 10 
months after surgery. A follow-up panoramic 
radiograph showed new bone formation after 
successful treatment.
Discussion
The lymphomas are a group of neoplasms arising 
in the reticuloendothelial and lymphatic system.
4,6 
They are divided into 2 major categories: non-
Hodgkin’s lymphoma (NHL) and Hodgkin’s 
disease (HD). Although these diseases usually 
present with lymphadenopathy or splenomegaly, 
extranodal sites,including bone tissues, can be 
involved with disease.
4,7,8
Malignant non-Hodgkin’s lymphomas may 
involve the medullar part of the bone during their 
evolution but only rarely arise primarily there.
9,10 
We present a rare case of primary lymphoma of 
the mandible. To our knowledge, there are only a 
few reports on this condition. Most such lympho-
mas have been shown to be predominantly of 
B-cell lineage.
11
Primary mandibular involvement makes up 
about 0.6% of all malignant non-Hodgkin’s lym-
phomas,
5 5% of all NHL of bone and accounts for 
8% all mandibular tumors.
3,8
The most frequent site of occurrence in the 
mandible is the body.
7,8,12
Owing to their low frequency and to their not 
specific symptoms, primary malignant non-
Hodgkin’s lymphomas of the mandible are often 
misdiagnosed.
1,9,11 These signs may lead to an 
incorrect diagnosis because of the resemblance to 
other common dental disease.
1,12 the clinical 
Figure 1. Panoramic radiograph showing a diffuse radiolucent lesion in lower left molar region.447
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presentation mirrors that of an odontogenic process 
or localized osteomyelitis.
3,13 Lesions are sometimes 
thought to be inﬂ  ammatory or infectious, therefore 
delaying diagnosis as was the case seen with the 
patient presented here.
1,3,7
The clinical presentation of mandibular NHL 
usually involves localized bone swelling, teeth 
mobility,
2,14 mass in an extraction socket, pain, 
pathologic fracture and often anesthesia or pares-
thesia along the distribution of the inferior alveolar 
nerve.
3,11
In this patient, Lymphoma was presented as 
mandibular intraosseous lesion. Paresthesia in 
mental region indicate compression or inﬁ  ltration 
of mandibular nervous tissue.
Despite extensive local destruction, systemic 
manifestations of malignant disease, such as weight 
loss, fever, and malaise, were very minimal.
7
This patient’s clinical presentation of a painful 
mass was consistent with reports of localized pain 
present at presentation. This mandibular swelling 
was initially thought to be due to an inﬂ  ammatory 
odontogenic/periodontal process and was treated 
as such with antibiotic and dental extraction.
In the head and neck region, lymphoma should 
be considered when there is unexplained dental 
pain, numbness, tooth mobility, swelling, ulceration, 
a mass in an extraction socket, or any ill-deﬁ  ned 
lytic osseous changes.
1
Histopathologic evaluation, together with immu-
nophenotypic and cytogenetic studies, elucidate the 
histologic type.
3 Immunohistochemistry plays an 
important role in distinguishing cell types and 
differential diagnosis;
1,13 a panel of monoclonal 
antibodies are used: CD20 (selective marker that 
recognizes a subpopulation of B-cells); CD10 (marker 
for follicular center B-cells and granulocytes), CD3 
(marker for T-cells and NK cells), CD30 (marker for 
activated T- and B-cells), ALK-1 (marker for ana-
plastic large cells) and Ki 67 (proliferation marker).
1,12 
For this case, the diagnosis was based on limited 
immunohistochemistry (CD20 and PanB).
Diffuse large B-cell lymphoma (formerly 
known as diffuse histiocytic lymphoma) is the most 
common subtype of NHL, including primary man-
dibular NHL.
3 In NHL of bone the cell architecture 
and histology is indistinguishable from nodal or 
lymphoid derived lymphomas.
1,3
Figure 2. Computed tomagraphy showing a wide osteolytic area in the left part of the mandible.448
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The work up should assess the extent of disease 
and allow for accurate staging.
The current staging procedures for extranodal 
oral lymphoma include a panoramic radiograph, 
abdominal and chest CT scan, bone scans, routine 
laboratory tests (hemogram, urine analysis, com-
plete blood cell counts, lactate dehydrogenase and 
erythrocyte sedimentation rate), and bone marrow 
aspiration biopsy.
1,3,7,13
There are no radiographic pathognomonic ﬁ  nd-
ings.
3,9,12 Radiographic features do not have spe-
ciﬁ  c characteristics, showing an osteolytic area. 
Often small areas of calciﬁ  cation can be seen in 
these masses.
7 Panoramic radiograph and CT scan 
are used to demonstrate local extension of non-
Hodgkin’s lymphoma, whereas total body CT scan 
with i.v. ioded medium and/or osseous scintiscan 
are used to exclude other sites and to stage the 
pathology.
9
To be classiﬁ  ed as a primary NHL of bone there 
must be no evidence of visceral or lymphatic 
involvement and no distant metastases for at least 
6 months following diagnosis.
3 The most widely 
used system for staging lymphomas is the Ann 
Arbor classification, initially introduced for 
Hodgkin’s lymphoma and later adopted to classify 
non-Hodgkin’s lymphomas.
5,11,15 Stage I comprises 
lymphomas localized and conﬁ  ned to one side of 
the diaphragm with a single lesion; Stage IE indi-
cates a single extralymphatic organ or site 
involved.
1,16
Stage I NHL has a 5-year survival rate of 70% 
and the median survival time for IE is 10 years.
2,3 
The 5-year survival rate for stage IE NHL of the 
maxillo-mandibular region is reported to be 
approximately 50%.
2,3,10
Treatment for primary lymphoma of the man-
dible typically consists of a combination of che-
motherapy and radiotherapy
3,10,15 and surgical 
approach is limited to obtaining a specimen repre-
sentative of the lesion and sufﬁ  cient for a complete 
histological examination.
5,9
Figure 3. Computed tomography showing a wide osteolytic area in the left part of the mandible.449
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Figure 4. Photomicrograph of the lymphoma showing bony trabeculae inﬁ  ltrated by lmphoid population with a diffuse growth pattern (H-E).
Figure 5. Photomicrograph of immunohistochemical stain shows sheets of large mononuclear cells positive for CD20.450
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The role of surgery is for biopsy purposes and 
for the control of persistent or recurrent local 
disease.
3
For this patient the follow-up was extremely 
short; the treatment consisted of only surgical 
excision, he showed complete remission with the 
disappearance of all clinical evidence of disease 
and the normalization radiologic abnormalities 
related to the disease. In spite of this clinical 
remission, a complement of radio and chemotherapy 
is discussed to improve prognosis but the patient 
refused that treatment.
Conclusion
Lymphomas are the most frequent nonepithelial 
malignant tumors in the oral cavity and maxillo-
facial region and represent the third most common 
group of malignant lesions in this site, following 
squamous cell carcinoma and salivary gland 
neoplasms.
1,11
We present a case of isolated mandibular NHL, 
stage IE. This report discusses this rare malignancy, 
including clinical presentation, histopathologic 
features, immunologic profile, treatment, and 
prognosis.
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